{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:14:34Z","timestamp":1770336874552,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nefroe.2026.501416","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:15:23Z","timestamp":1770293723000},"page":"501416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary VEGF-A165b mRNA expression in Fabry disease: Pilot study"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1462-2703","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Jaurretche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto","family":"Antongiovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"del Rosal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luana","family":"Brajkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Perretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Venera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2026.501416_bib0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2026.501416_bib0135","first-page":"215","article-title":"Prevalence of renal damage previous to the diagnosis of Fabry disease in Argentina","volume":"42","author":"Jaurretche","year":"2022","journal-title":"Rev Nefrol Di\u00e1l Trasplant"},{"key":"10.1016\/j.nefroe.2026.501416_bib0140","first-page":"101","article-title":"Enfermedad vascular en pacientes varones con enfermedad de Fabry en hemodi\u00e1lisis: estudio de cohorte retrospectivo en Argentina","volume":"39","author":"Jaurretche","year":"2019","journal-title":"Rev Nefrol Di\u00e1l Trasplant"},{"key":"10.1016\/j.nefroe.2026.501416_bib0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2019.10.010","article-title":"Pathogenesis of Fabry nephropathy: the pathways leading to fibrosis","volume":"129","author":"Rozenfeld","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nefroe.2026.501416_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1049-8","article-title":"Increased urinary CD80 excretion and podocyturia in Fabry disease","volume":"14","author":"Trimarchi","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.nefroe.2026.501416_bib0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.2010.484","article-title":"Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease","volume":"79","author":"Najafian","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2026.501416_bib0160","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nefro.2018.10.017","article-title":"Fabry nephropathy. Role of nephrologist and clinical variables associated with the diagnosis","volume":"39","author":"Jaurretche","year":"2019","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2026.501416_bib0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4236\/ojneph.2018.83009","article-title":"Urinary excretion of microRNAs in young Fabry disease patients with mild or absent nephropathy","volume":"8","author":"Jaurretche","year":"2018","journal-title":"Open J Nephrol"},{"key":"10.1016\/j.nefroe.2026.501416_bib0170","first-page":"4027606","article-title":"Variables associated with a urinary MicroRNAs excretion profile indicative of renal fibrosis in Fabry disease patients","author":"Jaurretche","year":"2019","journal-title":"Int J Chronic Dis"},{"key":"10.1016\/j.nefroe.2026.501416_bib0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mgene.2018.12.007","article-title":"Urinary excretion profile of microRNAs related to renal fibrosis in Fabry disease patients. A pilot study","volume":"19","author":"Jaurretche","year":"2019","journal-title":"Meta Gene"},{"key":"10.1016\/j.nefroe.2026.501416_bib0180","first-page":"594","article-title":"Possible role of Transforming Growth Factor-\u03b2eta on podocyte injury and microRNAs regulation in early Fabry nephropathy stages","volume":"11","author":"Jaurretche","year":"2020","journal-title":"Br J Med Health Sci"},{"key":"10.1016\/j.nefroe.2026.501416_bib0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nefroe.2026.501416_bib0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1386042","article-title":"The role of tubular cells in the pathogenesis of Fabry nephropathy","volume":"11","author":"Rozenfeld","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nefroe.2026.501416_bib0195","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/ijmm.2012.1139","article-title":"Possible role of transforming growth factor-\u03b21 and vascular endothelial growth factor in Fabry disease nephropathy","volume":"30","author":"Lee","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.nefroe.2026.501416_bib0200","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.0611315104","article-title":"Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities","volume":"104","author":"Moore","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nefroe.2026.501416_bib0205","doi-asserted-by":"crossref","first-page":"F1263","DOI":"10.1152\/ajprenal.00276.2002","article-title":"Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes","volume":"284","author":"Foster","year":"2003","journal-title":"Am J Physiol-Renal Physiol"},{"key":"10.1016\/j.nefroe.2026.501416_bib0210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.ki.5002101","article-title":"Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss","volume":"71","author":"Baelde","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2026.501416_bib0215","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2014040350","article-title":"Vascular endothelial growth factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy","volume":"26","author":"Oltean","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2026.501416_bib0220","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefroe.2026.501416_bib0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.nefroe.2026.501416_bib0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcell.2020.00123","article-title":"Diverse role of TGF-\u03b2 in kidney disease","volume":"8","author":"Gu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nefroe.2026.501416_bib0235","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.2337\/DB11-1655","article-title":"Vegfa protects the glomerular microvasculature in diabetes","volume":"61","author":"Sivaskandarajah","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.nefroe.2026.501416_bib0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm0110-40","article-title":"Kidney complications: factors that protect the diabetic vasculature","volume":"16","author":"Rask-Madsen","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2026.501416_bib0245","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2010030295","article-title":"Glomerular structure and function require paracrine, not autocrine VEGF\u2013VEGFR-2 signaling","volume":"21","author":"Sison","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2026.501416_bib0250","doi-asserted-by":"crossref","first-page":"F873","DOI":"10.1152\/ajprenal.00503.2010","article-title":"Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis","volume":"300","author":"Saito","year":"2011","journal-title":"Am J Physiol-Renal Physiol"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:16:16Z","timestamp":1770293776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251426000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2013251426000209"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501416","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary VEGF-A165b mRNA expression in Fabry disease: Pilot study","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501416"}}